BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 30027327)

  • 21. Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to pathological activation of the NF-κB signaling pathway.
    Pietsch T; Wohlers I; Goschzik T; Dreschmann V; Denkhaus D; Dörner E; Rahmann S; Klein-Hitpass L
    Acta Neuropathol; 2014 Apr; 127(4):609-11. PubMed ID: 24562983
    [No Abstract]   [Full Text] [Related]  

  • 22. Encouraging option of multi-staged gross total resection for a C11orf-RelA fusion-positive supratentorial anaplastic ependymoma.
    Nakamura T; Fukuoka K; Ikeda J; Yoshitomi M; Udaka N; Tanoshima R; Tateishi K; Yamanaka S; Ichimura K; Yamamoto T
    Brain Tumor Pathol; 2017 Oct; 34(4):160-164. PubMed ID: 28831588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ependymoma with C11orf95-MAML2 fusion: presenting with granular cell and ganglion cell features.
    Tamai S; Nakano Y; Kinoshita M; Sabit H; Nobusawa S; Arai Y; Hama N; Totoki Y; Shibata T; Ichimura K; Nakada M
    Brain Tumor Pathol; 2021 Jan; 38(1):64-70. PubMed ID: 33221956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological evaluation of PD-L1 expression and cytotoxic T-lymphocyte infiltrates across intracranial molecular subgroups of ependymomas: are these tumors potential candidates for immune check-point blockade?
    Nambirajan A; Malgulwar PB; Sharma A; Boorgula MT; Doddamani R; Singh M; Suri V; Sarkar C; Sharma MC
    Brain Tumor Pathol; 2019 Oct; 36(4):152-161. PubMed ID: 31388782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.
    Parker M; Mohankumar KM; Punchihewa C; Weinlich R; Dalton JD; Li Y; Lee R; Tatevossian RG; Phoenix TN; Thiruvenkatam R; White E; Tang B; Orisme W; Gupta K; Rusch M; Chen X; Li Y; Nagahawhatte P; Hedlund E; Finkelstein D; Wu G; Shurtleff S; Easton J; Boggs K; Yergeau D; Vadodaria B; Mulder HL; Becksfort J; Gupta P; Huether R; Ma J; Song G; Gajjar A; Merchant T; Boop F; Smith AA; Ding L; Lu C; Ochoa K; Zhao D; Fulton RS; Fulton LL; Mardis ER; Wilson RK; Downing JR; Green DR; Zhang J; Ellison DW; Gilbertson RJ
    Nature; 2014 Feb; 506(7489):451-5. PubMed ID: 24553141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infratentorial C11orf95-fused gliomas share histologic, immunophenotypic, and molecular characteristics of supratentorial RELA-fused ependymoma.
    Keenan C; Graham RT; Harreld JH; Lucas JT; Finkelstein D; Wheeler D; Li X; Dalton J; Upadhyaya SA; Raimondi SC; Boop FA; DeCuypere M; Zhang J; Vinitsky A; Wang L; Chiang J
    Acta Neuropathol; 2020 Dec; 140(6):963-965. PubMed ID: 33099686
    [No Abstract]   [Full Text] [Related]  

  • 27. The TP53 p.R337H mutation is uncommon in a Brazilian cohort of pediatric patients diagnosed with ependymoma.
    de Almeida Magalhães T; Borges KS; de Sousa GR; Brandalise SR; Seidinger AL; Scrideli CA; Oba-Shinjo SM; Yunes JA; Tone LG
    Neurol Sci; 2020 Mar; 41(3):691-694. PubMed ID: 31728854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A coordinated approach for the assessment of molecular subgroups in pediatric ependymomas using low-cost methods.
    de Sousa GR; Lira RCP; de Almeida Magalhães T; da Silva KR; Nagano LFP; Saggioro FP; Baroni M; Marie SKN; Oba-Shinjo SM; Brandelise S; de Paula Queiroz RG; Brassesco MS; Scrideli CA; Tone LG; Valera ET
    J Mol Med (Berl); 2021 Aug; 99(8):1101-1113. PubMed ID: 33903940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological and Genetic Features of Supratentorial Cortical Ependymomas.
    Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Date I
    World Neurosurg; 2019 Sep; 129():e417-e428. PubMed ID: 31150846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series.
    Benesch M; Mynarek M; Witt H; Warmuth-Metz M; Pietsch T; Bison B; Pfister SM; Pajtler KW; Kool M; Schüller U; Pietschmann K; Juhnke BO; Tippelt S; Fleischhack G; Schmid I; Kramm CM; Vorwerk P; Beilken A; Classen CF; Hernáiz Driever P; Kropshofer G; Imschweiler T; Lemmer A; Kortmann RD; Rutkowski S; von Hoff K
    Oncologist; 2019 Sep; 24(9):e921-e929. PubMed ID: 30850560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma.
    Tzaridis T; Milde T; Pajtler KW; Bender S; Jones DT; Müller S; Wittmann A; Schlotter M; Kulozik AE; Lichter P; Peter Collins V; Witt O; Kool M; Korshunov A; Pfister SM; Witt H
    Oncotarget; 2016 Sep; 7(38):61860-61873. PubMed ID: 27556362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling.
    Figarella-Branger D; Lechapt-Zalcman E; Tabouret E; Jünger S; de Paula AM; Bouvier C; Colin C; Jouvet A; Forest F; Andreiuolo F; Quintin-Roue I; Machet MC; Heitzmann A; Milin S; Sevestre H; Godfraind C; Labrousse F; Metellus P; Scavarda D; Pietsch T
    Neuro Oncol; 2016 Jul; 18(7):919-27. PubMed ID: 26984744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.
    Nobusawa S; Hirato J; Yokoo H
    Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling.
    Mack SC; Pajtler KW; Chavez L; Okonechnikov K; Bertrand KC; Wang X; Erkek S; Federation A; Song A; Lee C; Wang X; McDonald L; Morrow JJ; Saiakhova A; Sin-Chan P; Wu Q; Michaelraj KA; Miller TE; Hubert CG; Ryzhova M; Garzia L; Donovan L; Dombrowski S; Factor DC; Luu B; Valentim CLL; Gimple RC; Morton A; Kim L; Prager BC; Lee JJY; Wu X; Zuccaro J; Thompson Y; Holgado BL; Reimand J; Ke SQ; Tropper A; Lai S; Vijayarajah S; Doan S; Mahadev V; Miñan AF; Gröbner SN; Lienhard M; Zapatka M; Huang Z; Aldape KD; Carcaboso AM; Houghton PJ; Keir ST; Milde T; Witt H; Li Y; Li CJ; Bian XW; Jones DTW; Scott I; Singh SK; Huang A; Dirks PB; Bouffet E; Bradner JE; Ramaswamy V; Jabado N; Rutka JT; Northcott PA; Lupien M; Lichter P; Korshunov A; Scacheri PC; Pfister SM; Kool M; Taylor MD; Rich JN
    Nature; 2018 Jan; 553(7686):101-105. PubMed ID: 29258295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RELA Fusion in Supratentorial Extraventricular Ependymomas: A Morphologic, Immunohistochemical, and Molecular Study of 43 Cases.
    Wang L; Liu L; Li H; Wang P; Hu Z; Wei Y; Zhang M; Wen W; Li Z; Liu L; Zhao L; Lu D; Teng L
    Am J Surg Pathol; 2019 Dec; 43(12):1674-1681. PubMed ID: 31393268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric Supratentorial Ependymoma: Surgical, Clinical, and Molecular Analysis.
    Lillard JC; Venable GT; Khan NR; Tatevossian RG; Dalton J; Vaughn BN; Klimo P
    Neurosurgery; 2019 Jul; 85(1):41-49. PubMed ID: 29917116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supratentorial extra-axial RELA fusion-positive ependymoma misdiagnosed as meningioma by intraoperative histological and cytological examinations: a case report.
    Nagayasu MA; Fukushima T; Matsumoto F; Takeshima H; Sato Y; Kataoka H
    J Med Case Rep; 2022 Aug; 16(1):312. PubMed ID: 35986385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A De Novo Mouse Model of C11orf95-RELA Fusion-Driven Ependymoma Identifies Driver Functions in Addition to NF-κB.
    Ozawa T; Arora S; Szulzewsky F; Juric-Sekhar G; Miyajima Y; Bolouri H; Yasui Y; Barber J; Kupp R; Dalton J; Jones TS; Nakada M; Kumabe T; Ellison DW; Gilbertson RJ; Holland EC
    Cell Rep; 2018 Jun; 23(13):3787-3797. PubMed ID: 29949764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of Hedgehog signaling by the oncogenic RELA fusion reveals a primary cilia-dependent vulnerability in supratentorial ependymoma.
    de Almeida Magalhães T; Alencastro Veiga Cruzeiro G; Ribeiro de Sousa G; Englinger B; Fernando Peinado Nagano L; Ancliffe M; Rodrigues da Silva K; Jiang L; Gojo J; Cherry Liu Y; Carline B; Kuchibhotla M; Pinto Saggioro F; Kazue Nagahashi Marie S; Mieko Oba-Shinjo S; Andres Yunes J; Gomes de Paula Queiroz R; Alberto Scrideli C; Endersby R; Filbin MG; Silva Borges K; Salic A; Gonzaga Tone L; Valera ET
    Neuro Oncol; 2023 Jan; 25(1):185-198. PubMed ID: 35640920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C11orf95-RELA fusion present in a primary intracranial extra-axial ependymoma: Report of a case with literature review.
    Nambirajan A; Malgulwar PB; Sharma MC; Singh A; Pathak P; Satyarthee GD; Garg A
    Neuropathology; 2016 Oct; 36(5):490-495. PubMed ID: 27121356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.